Search
Displaying all 4 results
Pretomanid
go.drugbank.com/drugs/DB05154
ApprovedInvestigational
Persistent forms of tuberculosis (TB) have proven to be a major cause of global morbidity and mortality and a cause for significant concern. Research in recent years has been geared toward the development of novel therapies that target persistent forms of this disease, which have shown resistance to standard therapy...
Pretomanid Predicted Metabolism Pathway
smpdb.ca/view/SMP0174676MetabolicMetabolites of sildenafil are predicted with biotransformer.
Pulmonary Tuberculosis resistant to isoniazid, rifamycins, a fluoroquinolone and a second line injectable antibacterial drug
go.drugbank.com/conditions/DBCOND0154352Drugs: PretomanidPulmonary Rifampicin- and Isoniazid-Resistant Tuberculosis
go.drugbank.com/conditions/DBCOND0154353Drugs: Pretomanid